Skip to main content


Generic name: inebilizumab-cdon (injection, for intravenous use)
Drug class: Selective immunosuppressants

Medically reviewed by Judith Stewart, BPharm. Last updated on Jun 15, 2023.


Uplizna may cause serious side effects, including:
Infusion reactions. Uplizna can cause infusion reactions that can be serious or may cause you to be hospitalized. You will be monitored during your infusion and for at least 1 hour after each infusion of Uplizna for signs and symptoms of an infusion reaction. Tell your healthcare provider right away if you get any of these symptoms:

If you develop an infusion reaction, your healthcare provider may need to stop or slow down the rate of your infusion and treat your symptoms.
Infections. Infections can happen during treatment with Uplizna. Tell your healthcare provider right away if you have an infection or get any of these symptoms:

See Uplizna side effects for more information about side effects.

What is Uplizna?

Who should not receive Uplizna?

You should not receive Uplizna if you have:

Before receiving Uplizna

Before receiving Uplizna, tell you healthcare provider about all of your medical conditions, including if you:

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive Uplizna?

Uplizna side effects

Uplizna may cause serious side effects, including:

The most common side effects include urinary tract infection and joint pain.

These are not all the possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

General information about the safe and effective use of Uplizna.

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. You can ask your pharmacist or healthcare provider for information about Uplizna that is written for health professionals.

What are the ingredients in Uplizna?

Active ingredient: inebilizumab-cdon.
Inactive ingredients: L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80, sodium chloride, α,α-trehalose dihydrate, and water for injection.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.